Can a psychedelic trip plus a gentle ear zap lift depression?

NCT ID NCT06512194

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This study tests whether a single dose of psilocybin, taken with psychological support, can ease symptoms of major depression. It also explores whether adding a non-invasive device that gently stimulates the ear—called transcutaneous auricular vagus nerve stimulation—can boost or prolong the effects. Adults with major depressive disorder will receive the psilocybin capsule and then either real or sham ear stimulation, with follow-up measuring mood, social functioning, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
psilocybin, a psychedelic compound, given as a single 25 mg capsule with psychological support, plus transcutaneous auricular vagus nerve stimulation (taVNS) or a sham device
What this could lead to
If successful, this could point toward a new, rapid-acting treatment for major depression that combines a single psychedelic dose with a non-invasive nerve stimulation technique to enhance and prolong antidepressant effects.
What could go wrong
This is a phase 2 trial, so results are preliminary and may not generalize. Psilocybin can cause intense psychological effects and temporary distress, and the added benefit of taVNS is unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Vail Health Behavioral Health

    RECRUITING

    Edwards, Colorado, 81632, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.